纸质出版日期:2022-11-20,
网络出版日期:2022-04-29,
收稿日期:2022-01-26,
修回日期:,
录用日期:
扫 描 看 全 文
引用本文
朱冬菊,朴炳奎,秦腾腾等.基于PI3K/Akt信号通路探讨固本解毒方含药血清对肺癌A549细胞EMT的影响[J].中国实验方剂学杂志,2022,28(22):93-99.
ZHU Dongju,PIAO Bingkui,QIN Tengteng,et al.Effect of Guben Jiedu Prescription-medicated Serum on Epithelial-mesenchymal Transition of Lung Cancer A549 Cells: Based on PI3K/Akt Signaling Pathway[J].Chinese Journal of Experimental Traditional Medical Formulae,2022,28(22):93-99.
朱冬菊,朴炳奎,秦腾腾等.基于PI3K/Akt信号通路探讨固本解毒方含药血清对肺癌A549细胞EMT的影响[J].中国实验方剂学杂志,2022,28(22):93-99. DOI: 10.13422/j.cnki.syfjx.20221329.
ZHU Dongju,PIAO Bingkui,QIN Tengteng,et al.Effect of Guben Jiedu Prescription-medicated Serum on Epithelial-mesenchymal Transition of Lung Cancer A549 Cells: Based on PI3K/Akt Signaling Pathway[J].Chinese Journal of Experimental Traditional Medical Formulae,2022,28(22):93-99. DOI: 10.13422/j.cnki.syfjx.20221329.
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构